Zadaxin synthetic thymosin alpha 1 regulatory update

SCLN received notice of allowance for a Japanese patent covering the use of zadaxin alone and in combination with alpha interferon to treat hepatitis C. Zadaxin is marketed in Asia and is in Phase III...